Mycophenolate Mofetil

CAS No. 128794-94-5

Mycophenolate Mofetil( RS 61443 )

Catalog No. M11174 CAS No. 128794-94-5

Mycophenolate Mofetil(RS 61443) is a non-competitive, selective and reversible inhibitor of inosine monophosphate dehydrogenase I/II with IC50 of 39 nM and 27 nM, respectively.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 42 In Stock
100MG 57 In Stock
200MG 88 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Mycophenolate Mofetil
  • Note
    Research use only, not for human use.
  • Brief Description
    Mycophenolate Mofetil(RS 61443) is a non-competitive, selective and reversible inhibitor of inosine monophosphate dehydrogenase I/II with IC50 of 39 nM and 27 nM, respectively.
  • Description
    Mycophenolate Mofetil(RS 61443) is a non-competitive, selective and reversible inhibitor of inosine monophosphate dehydrogenase I/II with IC50 of 39 nM and 27 nM, respectively.
  • Synonyms
    RS 61443
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Inosine monophosphate dehydrogeN/Ase II ; Inosine monophosphate dehydrogeN/Ase I
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    128794-94-5
  • Formula Weight
    433.49
  • Molecular Formula
    CHNO
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 86 mg/mL (198.38 mM)
  • SMILES
    O=C(OCCN1CCOCC1)CC/C(C)=C/CC2=C(O)C3=C(COC3=O)C(C)=C2OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. nakanishi, T., et al., Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on rat cardiac allograft rejection. Int Immunopharmacol, 2010. 10(1): p. 91-7.
molnova catalog
related products
  • Diammonium Glycyrrhi...

    Diammonium glycyrrhizinate is a widely used anti-inflammatory agent isolated from the licorice root.

  • LDH-IN-1

    LDH-IN-1 is a novel pyrazole-based inhibitor of human lactate dehydrogenase (LDH) with IC50s of 32 and 27 nM for LDHA and LDHB, respectively.?LDH-IN-1 inhibits the growth of MiaPaCa2 pancreatic cancer and A673 sarcoma cells with IC50s of 2.23 and 1.21 μM).

  • AGI-6780

    AGI-6780 is a potent and selective inhibitor of IDH2 R140Q mutant with IC50 of 23 nM.